Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I169504-5mg | 5mg | In stock | $64.90 | |
I169504-10mg | 10mg | In stock | $90.90 | |
I169504-25mg | 25mg | In stock | $204.90 | |
I169504-50mg | 50mg | In stock | $299.90 | |
I169504-100mg | 100mg | In stock | $534.90 | |
I169504-200mg | 200mg | In stock | $963.90 |
Selective, reversible Usp14 inhibitor. Cell-permeable
Synonyms | 314245-33-5 | IU1 | 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one | 1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone | 1-[1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl]-2-pyrrolidin-1-ylethanone | 1-(1-( |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Selective, reversible Usp14 inhibitor (IC 50 = 4 μM). Enhances degradation of proteasome substrates. Reduces rate of ubiquitin chain trimming bound to cyclin B or other ubiquitin chains. Active in vitro . Cell-permeable.IU1 is an inhibitor of USP14, a deu |
Shipped In | Normal |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of ubiquitin specific peptidase 14 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | IU1 is a special Usp14 inhibitor with an IC50 of 4-5 μM. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488191043 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488191043 |
IUPAC Name | 1-[1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl]-2-pyrrolidin-1-ylethanone |
INCHI | InChI=1S/C18H21FN2O/c1-13-11-17(18(22)12-20-9-3-4-10-20)14(2)21(13)16-7-5-15(19)6-8-16/h5-8,11H,3-4,9-10,12H2,1-2H3 |
InChi Key | JUWDSDKJBMFLHE-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC(=C(N1C2=CC=C(C=C2)F)C)C(=O)CN3CCCC3 |
Isomeric SMILES | CC1=CC(=C(N1C2=CC=C(C=C2)F)C)C(=O)CN3CCCC3 |
WGK Germany | 3 |
PubChem CID | 675434 |
Molecular Weight | 300.37 |
PubChem CID | 675434 |
---|---|
ChEMBL Ligand | CHEMBL1410015 |
CAS Registry No. | 314245-33-5 |
RCSB PDB Ligand | IU1 |
PubChem SID | 488191043 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C23161016 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C23161055 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C23161171 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C23161172 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C23161173 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C23161191 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C2316821 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C2316822 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C2316823 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C2316829 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C2316830 | Certificate of Analysis | Dec 13, 2022 | I169504 |
C2316961 | Certificate of Analysis | Dec 13, 2022 | I169504 |
Pictogram(s) | GHS05 |
---|---|
Signal | Danger |
Hazard Statements | H318:Causes serious eye damage |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P317:Get emergency medical help. |
WGK Germany | 3 |
Starting at $241.90
1. Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, Gartner C, Dimova N, Hanna J, Gygi SP et al.. (2010) Enhancement of proteasome activity by a small-molecule inhibitor of USP14.. Nature, 467 (7312): (179-84). [PMID:20829789] |